Home › Funds › MPM BioImpact LLC › VIR

MPM BioImpact LLC position in VIR

VIR BIOTECHNOLOGY INC · Health Care

MPM BioImpact LLC reported holding 2,809,711 shares of VIR (VIR BIOTECHNOLOGY INC) in its Q3 2026 13F filing — a position valued at US$31.4M, representing 2.42% of its reported portfolio and ranking #17 among its reported holdings. MPM BioImpact LLC first reported this position in Q3 2026.

Latest position (Q3 2026)2.81M sh
Reported value held$31.41M
Portfolio Weight2.42%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's VIR position evolved

MPM BioImpact LLC first disclosed a stake in VIR in Q3 2026 at 2,809,711 shares (US$31.4M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 2.81M $31.41M New

About VIR and 13F data

VIR (VIR BIOTECHNOLOGY INC) is a Health Care company. 38 other funds we track also report a position in VIR — the largest reported positions include ARCH Venture Management, LLC (US$141.9M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$95.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VIR

All VIR fund holders →

FAQ

How long has MPM BioImpact LLC held VIR?

MPM BioImpact LLC has disclosed VIR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is MPM BioImpact LLC's current position in VIR?

As of Q3 2026, MPM BioImpact LLC holds 2.81M shares of VIR (VIR BIOTECHNOLOGY INC), valued at $31.41M, representing 2.42% of its reported portfolio and ranking #17.

Has MPM BioImpact LLC been buying or selling VIR?

In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in VIR.

Which other funds hold VIR?

Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.